Innovating Evaluation and Treatment of Intrapartum Fevers: Where Do We Go from Here? Academic Article uri icon

Overview

abstract

  • As intrapartum fevers are not always infectious in origin, determining whether antibiotics are indicated is challenging. We previously sought to create a point-of-care calculator using clinical data available at the time of an intrapartum fever to identify the subset of women who require antibiotic treatment to avoid maternal and neonatal morbidity. Despite the use of a comprehensive dataset from our institutions, we were unable to propose a valid and highly predictive model. In this commentary, we discuss why our model failed, as well as future research directions to identify and treat true intraamniotic infection. Developing a risk-stratification model is paramount to minimizing maternal and neonatal exposure to unnecessary antibiotics while allowing for early identification of women and babies at risk for infectious morbidity. KEY POINTS: · Determining whether antibiotics are indicated in intrapartum fever is challenging.. · Developing a risk-stratification model for febrile laboring women is critical to decreasing harm.. · A point-of-care calculator based on clinical and biomarker data is the necessary approach..

publication date

  • April 20, 2021

Research

keywords

  • Anti-Bacterial Agents
  • Labor, Obstetric

Identity

Scopus Document Identifier

  • 85104930266

Digital Object Identifier (DOI)

  • 10.1055/s-0041-1727279

PubMed ID

  • 33878764